000			01450 a2200397 4500
005			20250512202426.0
264		0	_c19841228
008			198412s 0 0 eng d
022			_a0160-2446
024	7		_a10.1097/00005344-198409000-00003 _2doi
040			_aNLM _beng _cNLM
100	1		_aRen, J H
245	0	0	_aThe dopamine congener, ibopamine, in congestive heart failure. _h[electronic resource]
260			_bJournal of cardiovascular pharmacology _c
300			_a748-55 p. _bdigital
500			_aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCardiotonic Agents _xpharmacology
650	0	4	_aDeoxyepinephrine _xanalogs & derivatives
650	0	4	_aDopamine _xanalogs & derivatives
650	0	4	_aFemale
650	0	4	_aHeart Failure _xphysiopathology
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aStroke Volume _xdrug effects
650	0	4	_aSystole _xdrug effects
700	1		_aUnverferth, D V
700	1		_aLeier, C V
773	0		_tJournal of cardiovascular pharmacology _gvol. 6 _gno. 5 _gp. 748-55
856	4	0	_uhttps://doi.org/10.1097/00005344-198409000-00003 _zAvailable from publisher's website
999			_c6209516 _d6209516